Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases
Clinical trial NCT06440954 · RECRUITING
Trial details
- NCT number
- NCT06440954
- Sponsor
- Hunan Province Tumor Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-12-31
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.